| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |